Angela R. Hicks Bowman - 15 Oct 2025 Form 4 Insider Report for Angi Inc. (ANGI)

Role
Director
Signature
/s/ Shannon M. Shaw, as Attorney-in-Fact for Angela R. Hicks Bowman
Issuer symbol
ANGI
Transactions as of
15 Oct 2025
Net transactions value
-$10,025
Form type
4
Filing time
17 Oct 2025, 17:24:20 UTC
Previous filing
18 Sep 2025
Next filing
03 Mar 2026

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
Hicks Bowman Angela R. Director C/O ANGI INC., 3601 WALNUT STREET, SUITE 700, DENVER /s/ Shannon M. Shaw, as Attorney-in-Fact for Angela R. Hicks Bowman 17 Oct 2025 0001534094

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ANGI Class A Common Stock, par value $0.001 Options Exercise +2,500 +9.8% 28,102 15 Oct 2025 Direct F1, F2
transaction ANGI Class A Common Stock, par value $0.001 Tax liability $10,025 -712 -2.5% $14.08 27,390 15 Oct 2025 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction ANGI Restricted Stock Units Options Exercise $0 -2,500 -25% $0.000000 7,500 15 Oct 2025 Class A Common Stock, par value $0.001 2,500 Direct F1, F3
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Restricted stock units convert into Class A Common Stock on a one-for-one basis.
F2 Effective on March 24, 2025, the Issuer effected a 1-for-10 reverse stock split of its common stock (the "Reverse Stock Split"). The amount of securities reported on this Form 4 have been adjusted to reflect the Reverse Stock Split.
F3 On October 15, 2024, the reporting person was granted 100,000 restricted stock units (on a pre-Reverse Stock Split basis), vesting in four equal annual installments beginning on the first anniversary of the grant date, subject to continued service.